{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T22:53:25Z","timestamp":1693954405366},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Gerontol Geriat"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s00391-015-0922-z","type":"journal-article","created":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T09:23:22Z","timestamp":1436261002000},"page":"483-493","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Analgetika beim geriatrischen Patienten"],"prefix":"10.1007","volume":"48","author":[{"given":"Markus","family":"Gosch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,8]]},"reference":[{"issue":"11\u201312","key":"922_CR1","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s10354-010-0788-z","volume":"160","author":"M Gosch","year":"2010","unstructured":"Gosch M, B\u00f6hmdorfer B, Benvenuti-Falger U, Dovjak P, Iglseder B, Lechleitner M, Otto R, Roller RE, Sommeregger U (2010) [Polypharmacy and pain treatment]. Wien Med Wochenschr 160(11\u201312):286\u2013292","journal-title":"Wien Med Wochenschr"},{"issue":"2","key":"922_CR2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1532-5415.1997.tb04501.x","volume":"45","author":"GP Stoehr","year":"1997","unstructured":"Stoehr GP, Ganguli M, Seaberg EC, Echement DA, Belle S (1997) Over-the-counter medication use in an older rural community: the MoVIES Project. J Am Geriatr Soc 45(2):158\u2013165","journal-title":"J Am Geriatr Soc"},{"key":"922_CR3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-2007-959300","volume":"132","author":"D Rottlaender","year":"2007","unstructured":"Rottlaender D, Scherner M, Schneider T, Erdmann E (2007) Multimedikation, Compliance und Zusatzmedikation bei Patienten mit kardiovaskul\u00e4ren Erkrankungen. Dtsch Med Wochenschr 132:139\u2013144","journal-title":"Dtsch Med Wochenschr"},{"key":"922_CR4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/fampra\/cml067","volume":"24","author":"U Junius Walker","year":"2007","unstructured":"Junius Walker U, Theile G, Hummers-Pradier E (2007) Prevalence and predictors of polypharmacy among older primary care patients in Germany. Family Pract 24:14\u201319","journal-title":"Family Pract"},{"issue":"4","key":"922_CR5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.amjopharm.2006.12.005","volume":"4","author":"P Sawyer","year":"2006","unstructured":"Sawyer P, Bodner EV, Ritchie CS, Allman RM (2006) Pain and pain medication use in community-dwelling older adults. Am J Geriatr Pharmacother 4(4):316\u2013324","journal-title":"Am J Geriatr Pharmacother"},{"key":"922_CR6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","volume":"329","author":"M Pirmohamed","year":"2004","unstructured":"Pirmohamed, M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM (2004) Adverse drug reactions as cause of admission to hospital: prospektive analysis of 18820 patients. BMJ 329:15","journal-title":"BMJ"},{"issue":"2","key":"922_CR7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2125.2006.02831.x","volume":"63","author":"M Laroche","year":"2007","unstructured":"Laroche M, Charmes JP, Nouaille Y, Picard N, Merle L (2007) Is inappropiate medication usea major cause of adverse drug reactions in the elderly. Br J Clin Pharmacol 63(2):177\u2013186","journal-title":"Br J Clin Pharmacol"},{"key":"922_CR8","doi-asserted-by":"crossref","unstructured":"Hoffmann F, Glaeske G, Schmiemann G (2015) Underuse of proton-pump inhibitors in older patients newly starting NSAID treatment. Int J Clin Pract. doi:10.1111\/ijcp.12611","DOI":"10.1111\/ijcp.12611"},{"issue":"4","key":"922_CR9","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1572-0241.2008.01811.x","volume":"103","author":"E Rahme","year":"2008","unstructured":"Rahme E, Barkun A, Nedjar H, Gaugris S, Watson D (2008) Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada. Am J Gastroenterol 103(4):872\u2013882","journal-title":"Am J Gastroenterol"},{"key":"922_CR10","doi-asserted-by":"crossref","unstructured":"Nagata N, Niikura R, Aoki T, Sakurai T, Moriyasu S, Shimbo T, Sekine K, Okubo H, Watanabe K, Yokoi C, Yanase M, Akiyama J, Uemura N (2015) Effect of proton-pump inhibitors on the risk of lower gastrointestinal bleeding associated with NSAIDs, aspirin, clopidogrel, and warfarin. J Gastroenterolmar 27 epub ahead of print pmid 25812518","DOI":"10.1007\/s00535-015-1055-2"},{"key":"922_CR11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(03)12509-3","volume":"361","author":"TM MacDonald","year":"2003","unstructured":"MacDonald TM, Wie L (2003) Effect of ibuprufen on cardioprotective effect of aspirin. Lancet 361:573\u2013574","journal-title":"Lancet"},{"key":"922_CR12","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1161\/01.CIR.0000132491.96623.04","volume":"109","author":"L Garcia-Rodriguez","year":"2004","unstructured":"Garcia-Rodriguez L, Varas-Lorenzo C, Maguire A, Gonz\u00e1lez-P\u00e9rez A (2004) Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population. Circulation 109:3000\u20133006","journal-title":"Circulation"},{"key":"922_CR13","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Poza P, de Abajo FJ, Gil MJ, Chac\u00f3n A, Bryant V, Garc\u00eda-Rodr\u00edguez LA (2015) Risk of ischemic stroke associated with non-steroidal anti-inflammatory drugs and paracetamol: a population-based case-control study. J Thromb Haemost. doi:10.1111\/jth.12855","DOI":"10.1111\/jth.12855"},{"issue":"4","key":"922_CR14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1503\/cmaj.070186","volume":"177","author":"JA Delaney","year":"2007","unstructured":"Delaney JA, Opatrny L, Brophy JM, Siussa S (2007) Drug-drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. CMAJ 177(4):347\u2013351","journal-title":"CMAJ"},{"issue":"8","key":"922_CR15","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/jama.2015.0809","volume":"313","author":"AM Schjerning Olsen","year":"2015","unstructured":"Schjerning Olsen AM, Gislason GH, McGettigan P, Fosb\u00f8l E, S\u00f8rensen R, Hansen ML, K\u00f8ber L, Torp-Pedersen C, Lamberts M (2015) Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction. JAMA 313(8):805\u2013814","journal-title":"JAMA"},{"issue":"10","key":"922_CR16","doi-asserted-by":"crossref","first-page":"690","DOI":"10.7326\/M13-1581","volume":"161","author":"M Lamberts","year":"2014","unstructured":"Lamberts M, Lip GY, Hansen ML, Lindhardsen J, Olesen JB, Rauns\u00f8 J, Olsen AM, Andersen PK, Gerds TA, Fosb\u00f8l EL, Torp-Pedersen C, Gislason GH (2014) Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study. Ann Intern Med 161(10):690\u2013698","journal-title":"Ann Intern Med"},{"issue":"1","key":"922_CR17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2036.2007.03541.x","volume":"27","author":"YK Loke","year":"2008","unstructured":"Loke YK, Trivel AN, Ingh S (2008) Meta-analysis: gastrointestinal bleeding due to interaction between selektive serotonin reuptake inhibitors and non steroidal inflammatory drugs. Aliment Pharmacol Ther 27(1):31\u201340","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"922_CR18","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/pds.1641","volume":"17","author":"HL Smets","year":"2008","unstructured":"Smets HL, De Haes JF, De Swaef A, Jorens PG, Verpooten GA (2008) Exposure of the elderly to potential nephrotoxic drug combinations in Belgium. Pharmacoepidemiol Drug Saf 17(10):1014\u20131019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"922_CR19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/ndt\/13.suppl_7.25","volume":"13","author":"A Baraldi","year":"1998","unstructured":"Baraldi A, Ballestri M, Rapana R, Lucchi L, Borella P, Leonelli M, Furci L, Lusvarghi E (1998) Acute renal failure of medical type in an elderly population. Nephrol Dial Transplant 13(Suppl 7):25\u201329","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"922_CR20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archinte.160.6.777","volume":"160","author":"J Page","year":"2000","unstructured":"Page J, Henry D (2000) Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underecognized public health problem. Arch Intern Med 160(6):777\u2013784","journal-title":"Arch Intern Med"},{"issue":"5","key":"922_CR21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002018-199717050-00001","volume":"17","author":"AG Johnson","year":"1997","unstructured":"Johnson AG (1997) NSAIDs and increased blood pressure. What is clinical significance? Drug Saf 17(5):277\u2013289","journal-title":"Drug Saf"},{"issue":"2","key":"922_CR22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ajg.2008.149","volume":"104","author":"L Laine","year":"2006","unstructured":"Laine L, Goldkind L, Curtis SP, Connors LG, Yanqiong Z, Cannon CP (2006) How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial. Am J Gastroenterol 104(2):356\u2013362","journal-title":"Am J Gastroenterol"},{"issue":"D","key":"922_CR23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/26.suppl_D.7","volume":"26","author":"R Janknegt","year":"1990","unstructured":"Janknegt R (1990) Drug interactions with quinolones. J Antimicrob Chemoter 26(Suppl D):7\u201329","journal-title":"J Antimicrob Chemoter"},{"issue":"4","key":"922_CR24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2165\/00044011-200929040-00006","volume":"29","author":"Z Iqbal","year":"2009","unstructured":"Iqbal Z, Khan A, Naz A, Khan JA, Khan GS (2009) Pharmacokinetic interaction of ciprofloxacin with diclofenac: a single dose, two-period crossover study in healthy adult volunteers. Clin Drug Investig 29(4):275\u2013281","journal-title":"Clin Drug Investig"},{"issue":"4","key":"922_CR25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7326\/0003-4819-134-4-200102200-00027","volume":"134","author":"H Sone","year":"2001","unstructured":"Sone H, Takahashi A, Yamada N (2001) Ibuprofen-related hypoglycaemia in a patient receiving sulfonylurea. Ann Intern Med 134(4):344","journal-title":"Ann Intern Med"},{"issue":"2","key":"922_CR26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.1365-2125.1999.00996.x","volume":"48","author":"M Collin","year":"1999","unstructured":"Collin M, Mucklow JC (1999) Drug interactions, renal impairment and hypoglycaemia in a patient with Type II diabetes. Br J Clin Pharmacol 48(2):134\u2013137","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"922_CR27","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/00000542-200504000-00019","volume":"102","author":"RS Sinatra","year":"2005","unstructured":"Sinatra RS, Jahr JS, Reynolds LW, Viscusi ER, Groudine SB, Payen-Champenois C (2005) Efficacy and safety of single and repeated administration of 1 gram intravenous acetominophen injection (paracetamol) for pain management after major orthopedic surgery. Anesthesiology 102(4):822\u2013831","journal-title":"Anesthesiology"},{"key":"922_CR28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s001080050083","volume":"38","author":"CH Gleiter","year":"1997","unstructured":"Gleiter CH (1997) Paracetamol \u2013 das sichere Analgetikum. Internist 38:707\u2013712","journal-title":"Internist"},{"issue":"2","key":"922_CR29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1096\/fj.07-8506com","volume":"22","author":"B Hinz","year":"2008","unstructured":"Hinz B, Cheremina O, Brune K (2008) Acetaminophen (paracetamol) is a selektive cyclooxygenase-2 inhibitor in man. FASEB J 22(2):383\u2013390","journal-title":"FASEB J"},{"key":"922_CR30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1742-7843.2006.pto_248.x","volume":"98","author":"A Gonzalez-Perez","year":"2006","unstructured":"Gonzalez-Perez A, Garcia Rodriguez L (2006) Upper gastrointestinal complications among users of paracetamol. Basic Clin Pharmacol Toxicol 98:297\u2013303","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"922_CR31","doi-asserted-by":"crossref","unstructured":"Roberts E, Delgado Nunes V, Buckner S, Latchem S, Constanti M, Miller P, Doherty M, Zhang W, Birrell F, Porcheret M, Dziedzic K, Bernstein I, Wise E, Conaghan PG (2015) Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis. pii: annrheumdis-2014-206914. doi:10.1136\/annrheumdis-2014-206914","DOI":"10.1136\/annrheumdis-2014-206914"},{"issue":"3","key":"922_CR32","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/01.HYP.0000177437.07240.70","volume":"46","author":"JP Forman","year":"2005","unstructured":"Forman JP, Stampfer MJ, Curhan GC (2005) Non-narcotic analgesic dose and risk of incident hypertension in US women. Hypertension 46(3):500\u2013507","journal-title":"Hypertension"},{"issue":"12","key":"922_CR33","first-page":"1621","volume":"91","author":"I Mah\u00e9","year":"2006","unstructured":"Mah\u00e9 I, Bertrand N, Drouet L, Bal Dit Sollier C, Simoneau G, Mazoyer E, Caulin C, Bergmann JF (2006) Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study. Haematologica 91(12):1621\u20131627","journal-title":"Haematologica"},{"key":"922_CR34","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/hep.20948","volume":"42","author":"AM Larson","year":"2005","unstructured":"Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, Reisch JS, Schi\u00f8dt FV, Ostapowicz G, Shakil AO, Lee WM, Acute Liver Failure Study Group (2005) Acetaminophen-induced acute liver failure: results of a US Multicenter, prospective study. Hepatology 42:1364\u20131372","journal-title":"Hepatology"},{"key":"922_CR35","first-page":"420","volume-title":"Analgetika mit antipyretischer und antiphlogistischer Wirkungskomponente. In: Arzneimittelneben- und -wechselwirkungen. Ammon, H.P.T.","author":"EJ Verspohl","year":"2001","unstructured":"Verspohl EJ (2001) Analgetika mit antipyretischer und antiphlogistischer Wirkungskomponente. In: Arzneimittelneben- und -wechselwirkungen. Ammon, H.P.T., 4.\u00a0Aufl. WVG, Stuttgart, S\u00a0420\u2013424","edition":"4"},{"issue":"13","key":"922_CR36","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.1986.03380130077032","volume":"256","author":"No authors listed","year":"1986","unstructured":"No authors listed (1986) Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The international agranulocytosis and aplastic anemia study. JAMA 256(13):1749\u20131757","journal-title":"JAMA"},{"issue":"18","key":"922_CR37","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.jacc.2013.07.039","volume":"62","author":"A Polzin","year":"2013","unstructured":"Polzin A, Zeus T, Schr\u00f6r K, Kelm M, Hohlfeld T (2013) Dipyrone (metamizole) can nullify the antiplatelet effect of aspirin in patients with coronary artery disease. J Am Coll Cardiol 62(18):1725\u20131726","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"922_CR38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.clpt.6100138","volume":"83","author":"T Saussele","year":"2007","unstructured":"Saussele T, Burk O, Blievernicht JK, Klein K, Nussler A, Nussler N, Hengstler JG, Eichelbaum M, Schwab M, Zanger UM (2007) Selective induction of human hepatic cytochromes P450 2B6 and 3A4 by Metamizole. Clin Pharmacol and Therap 83(3):265\u2013274","journal-title":"Clin Pharmacol and Therap"},{"key":"922_CR39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1213\/01.ane.0000189613.61910.32","volume":"102","author":"TH Enggaard","year":"2006","unstructured":"Enggaard TH, Poulsen L, Arendt-Nielsen L, Br\u00f8sen K, Ossig J, Sindrup SH (2006) The analgesic effect of tramadol after intravenous injection in healthy volunteers in relation to CYP2D6. Anesth Analg 102:146\u2013150","journal-title":"Anesth Analg"},{"key":"922_CR40","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1177\/014107689909200915","volume":"92","author":"S Kesavan","year":"1999","unstructured":"Kesavan S, Sobala GM (1999) Serotonin syndrome with fluoxetine plus tramadol. J R Soc Med 92:474\u2013475","journal-title":"J R Soc Med"},{"issue":"11","key":"922_CR41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5694\/j.1326-5377.2005.tb06825.x","volume":"182","author":"IW Boyd","year":"2005","unstructured":"Boyd IW (2005) Tramadol and seizures. Med J Aust 182(11):595\u2013596","journal-title":"Med J Aust"},{"issue":"6","key":"922_CR42","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1213\/00000539-200206000-00033","volume":"94","author":"R Arcioni","year":"2002","unstructured":"Arcioni R, della Rocca M, Roman\u00f2 S, Romano R, Pietropaoli P, Gasparetto A (2002) Ondansetron inhibits the analgesic effects of tramadol: a possible 5-HT(3) spinal receptor involvement in acute pain in humans. Anesth Analg 94(6):1553\u20131557","journal-title":"Anesth Analg"},{"issue":"5","key":"922_CR43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00228-004-0783-7","volume":"60","author":"K Hedenmalm","year":"2004","unstructured":"Hedenmalm K, Lindh JD, Sawe J, Rane A (2004) Increased liability of tramadol-warfarin interaction in individuals with mutations in the cytochrome P450 2D6 gene. Eur J Clin Pharmacol 60(5):369\u2013372","journal-title":"Eur J Clin Pharmacol"},{"issue":"5\u20136","key":"922_CR44","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00228-005-0947-0","volume":"61","author":"F Penning-van Beest","year":"2005","unstructured":"Penning-van Beest F, Erkens J, Petersen KU, Koelz HR, Herings R (2005) Main comedications associated with major bleeding during anticoagulant therapy with coumarins. Eur J Clin Pharmacol 61(5\u20136):439\u2013444","journal-title":"Eur J Clin Pharmacol"},{"key":"922_CR45","unstructured":"http:\/\/www.awmf.org\/leitlinien\/detail\/ll\/145-003.html (09.05.2015)"},{"issue":"8","key":"922_CR46","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF03016672","volume":"55","author":"ST Rang","year":"2008","unstructured":"Rang ST, Field J, Irving C (2008) Serotonin toxicity caused by an interaction between fentanyl and paroxetine. Can J Anaesth 55(8):521\u2013525","journal-title":"Can J Anaesth"},{"issue":"2","key":"922_CR47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2710.2007.00813.x","volume":"32","author":"S Ailawadhi","year":"2007","unstructured":"Ailawadhi S, Sung KW, Carlson LA, Baer MR (2007) Serotonin syndrome caused by interaction between citalopram and fentanyl. J Clin Pharm Ther 32(2)199\u2013202","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"922_CR48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40263-013-0038-1","volume":"27","author":"KC S\u00f6derberg","year":"2013","unstructured":"S\u00f6derberg KC, Laflamme L, M\u00f6ller J (2013) Newly initiated opioid treatment and therisk of fall-related injuries. A nationwide, register-based, case-crossover study in Sweden. CNS Drugs 27(2):155\u2013161","journal-title":"CNS Drugs"},{"issue":"2","key":"922_CR49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/gerona\/61.2.165","volume":"61","author":"A Win","year":"2006","unstructured":"Win A, Lapane KL, Vallow S, Schein J, Morris JN, Lipsitz LA (2006) Long-term effects of analgesics in a population of elderly nursing home residents with peristent nonmalignant pain. J Gerontol A Biol Sci Med 61(2):165\u2013169","journal-title":"J Gerontol A Biol Sci Med"},{"issue":"6","key":"922_CR50","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.amjopharm.2012.09.004","volume":"10","author":"CK O\u2019Neil","year":"2012","unstructured":"O\u2019Neil CK, Hanlon JT, Marcum ZA (2012) Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics. Am J Geriatr Pharmacother 10(6):331\u2013342","journal-title":"Am J Geriatr Pharmacother"},{"issue":"1","key":"922_CR51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ageing\/afq140","volume":"40","author":"A Clegg","year":"2012","unstructured":"Clegg A, Young JB (2012) Which medications to avoid in people at risk of delirium: a systematic review. Age Ageing 40(1):23\u201329","journal-title":"Age Ageing"},{"issue":"5","key":"922_CR52","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/ACO.0b013e32833c345a","volume":"23","author":"HL Rittner","year":"2010","unstructured":"Rittner HL, Roewer N, Brack A (2010) The clinical (ir)relevance of opioid-induced immune suppression. Curr Opin Anaesthesiol 23(5):588\u2013592","journal-title":"Curr Opin Anaesthesiol"},{"issue":"41","key":"922_CR53","first-page":"12","volume":"111","author":"H Petri","year":"2014","unstructured":"Petri H (2014) Therapie mit Opioiden: Was es zu beachten gilt. Dtsch Arztebl 111(41):12","journal-title":"Dtsch Arztebl"}],"container-title":["Zeitschrift f\u00fcr Gerontologie und Geriatrie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-015-0922-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00391-015-0922-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-015-0922-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T18:54:03Z","timestamp":1599245643000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00391-015-0922-z"}},"subtitle":["Unerw\u00fcnschte Arzneimittelwirkungen und Interaktionen"],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["922"],"URL":"https:\/\/doi.org\/10.1007\/s00391-015-0922-z","relation":{},"ISSN":["0948-6704","1435-1269"],"issn-type":[{"value":"0948-6704","type":"print"},{"value":"1435-1269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}